Reem Ghalib
- Hepatology top 0.2%
- Epidemiology top 1%
- Infectious Diseases top 5%
- Surgery
- Rheumatology top 5%
- Co-authors
- Eric LawitzMitchell L. ShiffmanBruce R. BaconLisa M. NybergMark SulkowskiJohn G. McHutchisonK. Rajender ReddyStephanie Noviello
- Topics
- Hepatitis C virus research (31 papers)Liver Disease Diagnosis and Treatment (22 papers)Hepatitis B Virus Studies (13 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Reem Ghalib
47 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hepatology 2.7k
- Epidemiology 2.3k
- Infectious Diseases 547
- Surgery 259
- Rheumatology 251
Countries citing papers authored by Reem Ghalib
This map shows the geographic impact of Reem Ghalib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reem Ghalib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reem Ghalib more than expected).
Fields of papers citing papers by Reem Ghalib
This network shows the impact of papers produced by Reem Ghalib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reem Ghalib. The network helps show where Reem Ghalib may publish in the future.
Co-authorship network of co-authors of Reem Ghalib
This figure shows the co-authorship network connecting the top 25 collaborators of Reem Ghalib. A scholar is included among the top collaborators of Reem Ghalib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reem Ghalib. Reem Ghalib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | OUTCOMES OF PATIENTS INTERRUPTING GLECAPREVIR/PIBRENTASVIR TREATMENT: A CASE SERIES FROM CLINICAL TRIALS | 2 |
| 2 | 11 | |
| 3 | 2 | |
| 4 | 234 | |
| 5 | 9 | |
| 6 | 14 | |
| 7 | Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1breakdown → | 454 |
| 8 | 36 | |
| 9 | 60 | |
| 10 | Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infectionbreakdown → | 889 |
| 11 | Hematologic Safety Data From the IDEAL Trial: Neutropenia, Anemia, and Thrombocytopenia Profiles of Peginterferon alfa/Ribavirin | 1 |
| 12 | 74 | |
| 13 | 66 | |
| 14 | 49 | |
| 15 | 71 | |
| 16 | 4 | |
| 17 | 22 | |
| 18 | 226 | |
| 19 | 7 | |
| 20 | 6 |
About Reem Ghalib
Reem Ghalib is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 47 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (22 papers) and Hepatitis B Virus Studies (13 papers). The work is most often cited by research in Hepatology (2.7k citations), Epidemiology (2.3k citations) and Infectious Diseases (547 citations). Reem Ghalib has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Eric Lawitz, Mitchell L. Shiffman, Bruce R. Bacon, Lisa M. Nyberg, Mark Sulkowski, John G. McHutchison, K. Rajender Reddy, Stephanie Noviello, Clifford A. Brass and Janice K. Albrecht. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.